P53 protein overexpression in verrucous carcinoma of the skin

Developmental Neuroscience

Volumn 192, Issue 1, 1996, Pages 12-15

  Noel, J C ^a   Petty, M O ^a   Dobbeleer, G De ^a   Thiriar, S ^a   Fayt, I ^a   Hoot, J ^a   Heenenh, M ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

P53 protein; Verrucous carcinoma

Indexed keywords

MONOCLONAL ANTIBODY; NUCLEAR PROTEIN; PROTEIN P53;

AGED; ARTICLE; CELL TRANSFORMATION; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; PATHOGENESIS; PRIORITY JOURNAL; SKIN CARCINOGENESIS; VERRUCOUS CARCINOMA;

EID: 0030024109     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000246305     Document Type: Article

References (39)

1. Lane DP. Crawford LV: T antigen is bound to a host protein in SV40-lransl'ornied cells. Nature 1979;278:261-263.
2. Lane DP. Renchitnol S: p53: Oncogene or anti-oncogene? Genes Dev 1990:4:1-8.
3. Levine AJ. Montand J. Finlay CA: The p53 tumour suppressor gene. Nature 1991:351: 453-456.
4. Bartek J. Bankova J. Vojtesek B. Staskova Z. Lukas J. Rejthar A. Kovarik J. Midgley CA. Gannon JV. Lane DP: Aberrant expression of the p53 protein is a common feature of a wide spectrum of human malignancies. Oncogene 1991:6:1699-1703.
5. Porter PL. Gown AM. Kramp SG. Collera MD: Widespread p53 overexpression in human malignant tumors. Am J Pathol 1992:140: 145-153.
6. Ilolistein M. Sidransky D. Vogelstein B. Ilarris CC: p53 mutations in human cancers. Science 1991:253:49-53.
7. Nigro JM. Baker SJ. Preisinger AC. Jessup JM. Hosteller R. Cleary K. Bigner SH. Davidson N. Baylin S. Devilec P. Glover T. Collins FS. Weston A. Modali R. Harris CC. Vogel-stein B: Mutations in the p53 gene occur in diverse human tumour types. Nature 1989:342: 705-709.
8. Bartek J. Barkova J. Lukas J. Staskova B. Vojtesek B. Lane DP: Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies. J Pathol 1993:169:27-34.
9. Van Den Berg FM. Baas IO. Polak MM. Ol'fa-haus JA: Detection of the p53 overexpression in routinely paraffin embedded tissue of human carcinomas using a novel target unmasking fluid (TUF). Am J Pathol 1993:142:381-385
10. Kerns BJ. Jordan PA. Moore MB. Humphrey PA. Berchuck A. Kohler MF. Bast RC. Igleharl JD. Marks JR: p53 overexpression in Formalin-fixed. paraffin-embedded tissue detected by immunohistochemistry. J llistochem Cyto-chcm 1992:40:1047-1051.
11. Sim CS. Slater S. McKee PH: Mutant p53 expression in solar keratosis: An immunohistochemical study. J Culan Pathol 1992:19: 302-308.
12. Gustcrson BA. Anhahagan R. Warren W. Midgely C. Lane DP. O'Hare M. Stamps A. Carter R. Jayatilare H: Expression of p53 in prcmalignant and malignant squamous epi-thelium. Oncogene 1991;6:1785-1789
13. Helandcr SD. Peters MS. Pittelkow MR: Expression of p53 protein in benign and malignant epidermal pathologic conditions. J Am Acad Dermatol 1993:29:741-748.
14. Kao GF. Graham JH. Helwig EB: Carcinoma cuniculatum (verrucous carcinoma of the skin). Cancer 1982:49:2395-2404.
15. Prioleau PG. Santa Cruz DJ. Meyer JS. Bauer WC: Verrucous carcinoma: A light and electron microscopic, autoradiographic and immunofluorescence study. Cancer 1980:45: 2849-2857.
16. McKee PH. Wilkinson JD. Black MM. Whim-ster IW: Carcinoma cuniculatum: A clinico-pathologic study of nineteen cases and review of the literature. Histopathology 1981:5: 425-436.
17. Kerschmann Rl. McCalmcnt TH. Le Boit P: p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma. Arch Dermatol 1994:130: 181-186.
18. Brownstein MH. Shapiro L: Verrucous carcinoma of skin: Epithelioma cuniculatum plan-tare. Cancer 1976:38:1708-1716.
19. Schwartz RA: Buschke-Loewenstein tumor: Verrucous carcinoma of the penis. J Am Acad Dermatol 1990:23:723-727.
20. Boshart M. Zur Hausen H: Human papillomaviruses in Busckc-Loewenstein tumors: Physical state of the DNA and identification of a tandem of duplication in the noncoding region of a human papillomavirus 6 subtype. J Virol 1986:58:963-966.
21. Garven TC. Thelmo WL. Victor J. Pertschuk L: Verrucous carcinoma of the leg positive for human papillomavirus DNA 11 and 18: A case report. Hum Pathol 1991:22:1170-1173.
22. Noël JC, Vanden Bossche M. Petty MO. Sas-sine A. De Dobbeleer G. Schulman CC. Verliest A: Verrucous carcinoma of the penis: Importance of human papillomavirus typing for diagnosis and therapeutic decision. Eur Urol 1992:22:83-85.
23. Noël JC. Pcny MO. Detrcmmerie O. Verliest A. Heenen M. Thiry L. De Dobbeleer G: Demonstration of human papillomavirus type 2 in a verrucous carcinoma of the foot. Dermatology 1993:187:58-61.
24. Noël JC. Pény MO. Goldschmidt D. Verliest A. Heenen M. De Dobbeleer G: Human papillomavirus type I DNA in verrucous carcinoma of the leg. J Am Acad Dermatol 1993:29: 1036-1038.
25. Ubben K. Krzyzek R. Ostrow R. Bender M. Zelickson A. Faras A. Pass F: Human papillomavirus DNA detected in two verrucous carcinomas. J Invest Dermatol 1979:72:195.
26. Lane S. Wells M: Human papillomaviruses. p53. And cervical neoplasia. J Pathol 1994:172: 299-300.
27. Kucrbitz SJ. Plunkett BS. Walsh WV. Kastan MB: Wild type p53 is a cell cycle checkpoint determinant following irradiation. Proe Natl Acad USA 1992:89:7491-7495.
28. Yonish-Rouach E. Resnitzky D. Loteni J. Sachs L. Kimclii A. Oren M: Wild-type p53 induces apoptosis of myeloid leukacmic cells that is inhibited by interleukin-6. Nature 1991: 352:345-347.
29. Sim CS. Slater SD. McKee PH: Mutant p53 protein is expressed in Bowen's disease. Am J Dcrmatopathol 1992:14:195-199.
30. McGregor JM. Yu CC. Dublin EA. Levison DA. McDonald DM: Aberrant expression of p53 tumour-suppressor protein in nonmelanoma skin cancer. Br J Dermatol 1992: 127:463-469.
31. Oram Y. Orengo I. Baer SC. Ocal T: p53 protein expression in squamous cell carcinomas from sun-exposed and non-sun-exposed sites. J Am Acad Dermatol 1994:31:417-422.
32. Brash DE. Rudolph JA. Simon JA. Lin A. McKenna GJ. Baden HP. Halperin AJ. Ponten Y: A role for sunlight in skin cancer: UV-induccd p53 mutation in squamous cell carcinoma. Proc Natl Acad Sei USA 1991:88: 10124-10128.
33. Kastan MB. Onyekwcrc O. Sidransky D. Vogelstein B. Craig RW: Participation of p53 prole n in the cellular response to DNA damage. Cancer Res 1991:51:4279-4286.
34. Clark LJ. McKenzie K. Parkinson EK: Elevated levels of the p53 tumour suppressor protein in the basal layer of recurrent laryngeal papillomas: in Stanley MA (ed): Immunology of Human Papillomaviruses: ed 1. New York, Plenum Press. 1994. pp 21-24.
35. Lee YS. Tell M: p53 expression in pseudoepi-thclkmiatous hyperplasia, keratoacanthoma and squamous cell carcinoma of skin. Cancer 1994:73:2317-2322.
36. Hall PA. Lane DP: p53 in tumor pathology: Can we trust immunohistochemistry? Revisited! J Pathol 1994:172:1-4.
37. Baltifora H: p53 immunohistochemistry: A word of caution. Hum Pathol 1994:25: 435-436.
38. McNutt NS. Saenz-Sanlamaria C. Volkenandt M. Shea CR. Albino A: Abnormalities of p53 protein expression in cutaneous disorders. Arch Dermatol 1994:130:225-232.
39. Noël JC. Heenen M. Pény M-O. Fayt I. De Dobbeleer G. Haol J. Galand P: Proliferating cell nuclear antigen (PCNA) distribution in verrucous carcinoma of the skin. Br J Dermatol. in press